Janction (JCT) fluctuates 82.0% in 24 hours: trading volume surges driven by futures leverage speculation
Bitget Pulse2026/04/04 23:52Volatility Overview
In the past 24 hours, JCT price rebounded from a low of $0.0024 to a high of $0.004369, currently at $0.0039, with an amplitude of 82.0%. Trading volume surged from $57.61 million to $80.76 million, an increase of several times or 765% compared to the previous day, signaling possible net capital inflow, with market capitalization around $42 million to $44 million.
Brief Analysis of the Cause of the Volatility
- Significant surge in trading volume: In 24 hours, the volume spiked from a typical few million dollars to $20.7–76.7 million, accounting for over 27.85% of the market cap, directly triggering intense price volatility.
- Active futures leverage trading: Bull and bear futures trading volume soared by more than 1300%, with total JCT holdings liquidated across the network reaching $75,200, fueling speculative rebounds.
Market View and Outlook
Market sentiment is mostly speculative and optimistic. The community and Bitget Pulse reports emphasize the so-called “speculative rebound” driven by trading volume and futures, but also warn that high leverage may cause pullbacks; trading signals indicate a potential short-term retest of the $0.0023 support level, with further downside risk if there is no strong reversal.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.